Business Context and Reporting Period
This Form 8-K Current Report was filed by SANUWAVE Health, Inc. on October 22, 2024. The report discloses the grant of stock options to current and former executive officers under the Company's 2024 Equity Incentive Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation arrangements.
Material Changes and Executive Compensation
On October 22, 2024, the Company granted stock options to four individuals. The terms of these grants are as follows:
- Exercise Price: $14.20 per share (closing price on the grant date).
- Vesting Schedule: 12 equal installments on each quarterly anniversary of the grant date.
- Term: Ten years.
Option Grants by Recipient:
| Name | Number of Stock Options |
|---|---|
| Morgan Frank | 160,000 |
| Peter Sorensen | 88,000 |
| Tim Hendricks | 50,667 |
| Kevin A. Richardson, II | 66,667 |
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the standard terms of the equity plan.
Investor Verification Checklist
- Verify the total number of options granted (365,334) and the associated dilution impact.
- Confirm the vesting schedule details in the attached Form of Stock Option Award Agreement (Exhibit 10.1).
- Review the Company's 2024 Equity Incentive Plan to ensure sufficient shares were available for these grants.
- Check the status of the recipients (current vs. former officers) to understand retention implications.